Wu, Audrey H.
March 2007
Heart;Mar2007, Vol. 93 Issue 3, p403
Academic Journal
The article discusses the management of patients with non-ischemic cardiomyopathy (NICM) manifesting with left ventricular systolic dysfunction. NICM is characterized by myocardial dysfunction resulting from a variety of causes. Pharmacologic treatment includes angiotensin-converting enzyme inhibitors and beta-blockers. Other management strategies include device therapy and surgery.


Related Articles

  • β‐blockers in left ventricular systolic dysfunction—from evidence to practice. BANDYOPADHYAY, SYAMASIS; O'MAHONY, M. SINEAD // Age & Ageing;Jan2002, Vol. 31 Issue 1, p23 

    Five percent of all hospital medical admissions are patients with heart failure. The incidence is about one new case per 1000 of the general population per year, increasing to >10 per 1000 in those aged 85 years. Although the evidence that β‐blockers reduce mortality by about 36%...

  • 178 Influence of the angiotensin-converting enzyme genotype on the response to beta-blocker therapy and the prognosis of the patients with chronic heart failure. Metra, M.; Nodari, S.; Pezzali, N.; Moiza Culot, L.; Fracassi, F.; Covolo, L.; Gelatti, U.; Donato, F.; Nardi, G.; Dei Cas, L. // European Journal of Heart Failure. Supplements;Jun2004, Vol. 2 Issue 1, p34 

    An abstract of the article "Influence of the Angiotensin-Converting Enzyme Genotype on the Response to Beta-Blocker Therapy and the Prognosis of the Patients With Chronic Heart Failure," by M. Metra and colleagues is presented.

  • ACE inhibitors and beta-blockers.  // Patient Care;12/15/1997, Vol. 31 Issue 20, p92 

    Examines the effects of angiotensin-converting enzyme (ACE) inhibitors and beta blockers on the long-term outcome of several cardiovascular disorders. Increase in the number of prescriptions being made for beta blockers for cases of hyperthension; Findings of studies published on the drugs;...

  • In patients with diabetes and hypertension, should treatment start with an ACE inhibitor instead of a diuretic or beta blocker? Mackrides, Paula S.; Shaughnessy, Allen F. // Journal of Family Practice;Mar2002, Vol. 51 Issue 3, p203 

    The article discusses research being done on the treatment of diabetics with hypertension using angiotensin converting enzyme inhibitor instead of a diuretic or beta blocker. It references a study by D. Niskanes et al published in a 2001 issue of "Diabetes Care." This randomized controlled trial...

  • Clinical Clips. Kirchner, Jeffrey; Pohl, Charles A.; Russell, John J. // Patient Care for the Nurse Practitioner;Nov2003, Vol. 6 Issue 11, p3 

    The article presents various clinical clips. The mortality benefits of drug therapy with angiotensin converting enzyme inhibitors, beta-blockers, and spironolactone for congestive heart failure (CHF) have been well established by multiple clinical trials. It was proposed that yet another class...

  • Peripartum cardiomyopathy: Ten year experience at a tertiary care hospital in Pakistan. Laghari, Abid Hussain; Khan, Aamir Hameed; Kazmi, Khawar Abbas // BMC Research Notes;2013, Vol. 6 Issue 1, p1 

    Background There is very little literature regarding peripartum cardiomyopathy from the Asian countries. We conducted this study to determine demographic details, clinical presentations, complications and recovery of left ventricular (LV) systolic function in peripartum cardiomyopathy (PPCMP)...

  • Predictores clínicos de tormenta arrítmica en pacientes con cardiomiopatía Chagásica con un desfibrilador automático implantable. Flores-Ocampo, Jorge; Nava, Santiago; Márquez, Manlio F.; Gómez-Flores, Jorge; Colín, Luis; López, Atala; Celaya, Manuel; Treviño, Ernesto; González-Hermosillo, Jesús Antonio; Iturralde, Pedro // Archivos de Cardiología de México;oct-dic2009, Vol. 79 Issue 4, p263 

    Objectives. To define the predictive factors of electrical storm (ES) in patients with Chronic Chagas Heart Disease (CCh) with an imptantable cardioverter defibrilator (lCD). Material and methods. We retrospectively studied 21 consecutive patients with CCh in whom an ICD was implanted between...

  • Negative Ionotropic Agents for the Treatment of Left Ventricular Outflow Tract Obstruction Due to Sigmoid Septum and Concentric Left Ventricular Hypertrophy Ranasinghe, Isuru; Yeoh, Thomas; Yiannikas, John // Heart, Lung & Circulation;Sep2011, Vol. 20 Issue 9, p579 

    Background: Negative ionotropic agents are established treatments for left ventricular outflow tract obstruction (LVOTO) in hypertrophic cardiomyopathy (HCM). However, their benefit in those with LVOTO without typical HCM is unclear. We evaluated if negative ionotropic agents are beneficial in...

  • Takotsubo cardiomyopathy. Cuculi, F.; Lim, C. C. S.; Banning, A. P. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/22/2010, Vol. 340 Issue 7756, p1095 

    The article offers clinical information on takotsubo cardiomyopathy, a condition characterized by acute, reversible left ventricular dysfunction that does not correlate with epicardial coronary artery blood supply. Takotsubo cardiomyopathy commonly affects postmenopausal women and is usually...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics